|Articles|May 16, 2012

Surya Singh, MD, Addresses Ways to Manage Oncology Spending in Specialty Pharmacy

Dr. Singh discusses CVS Caremark's strategies for managing oncology spending.

Surya Singh, MD, Vice President, Medical Benefit Management, CVS Caremark, states that there are a variety of approaches used to stem the rise of costs associated with oncology. However, Dr. Singh point out that there is not a one-size-fits-all approach to doing so.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Dr Shannon L. Maude | Image Credit: CHOP

Tisagenlecleucel Yields Promising Disease-Free Survival in High-Risk Pediatric ALL: Shannon L. Maude, MD, PhD

ByBrooke McCormick,Shannon L. Maude, MD, PhD

June 11th 2026

Dr Eunice S. Wang | Image Credit: Roswell Park Comprehensive Cancer Center

Ziftomenib Plus 7+3 Yields Strong Responses in NPM1-Mutated, KMT2A-Rearranged AML: Eunice S. Wang, MD

ByBrooke McCormick,Eunice Wang, MD

June 11th 2026

Dr David Kuter | Image Credit: Massachusetts General Hospital

Long-Term Extension Data Support Durable Benefit of Rilzabrutinib in Persistent, Chronic ITP: David Kuter, MD, DPhil

ByBrooke McCormick,David Kuter, MD, DPhil

June 11th 2026

Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD

ByPearl Steinzor,Sandra Chaparro, MD

June 11th 2026

Navigation services became a requirement under the OCM, and today CMS has reimbursement codes to cover some services. Scholars and physicians who revisit the OCM a decade after its arrival find it has forever changed care delivery for the better.| Image: forenna for adobe.com

Special Report: The Oncology Care Model, 10 Years Later

ByMary Caffrey

June 10th 2026

Surya Singh, MD, Addresses Ways to Manage Oncology Spending in Specialty Pharmacy

Related Content

Tisagenlecleucel Yields Promising Disease-Free Survival in High-Risk Pediatric ALL: Shannon L. Maude, MD, PhD

Ziftomenib Plus 7+3 Yields Strong Responses in NPM1-Mutated, KMT2A-Rearranged AML: Eunice S. Wang, MD

Long-Term Extension Data Support Durable Benefit of Rilzabrutinib in Persistent, Chronic ITP: David Kuter, MD, DPhil

Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD

Special Report: The Oncology Care Model, 10 Years Later

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications